Rho Pharmaceuticals
Glen Mills, US · Founded 2016 · Pennsylvania LLC
Founders & leadership
KJ
Kevin J. O'NeillNamed on SEC filing
NP
Nagesh PalepuNamed on SEC filing
HP
Hitha PalepuNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.3M disclosed across 1 round · 2017
▶$2.3MraisedDec 2018 · BiotechnologyRule 506(b)
▶$2.3MraisedDec 2018 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kevin J. O'NeillExecutive Officer, Director
- Nagesh PalepuExecutive Officer, Director
- Hitha PalepuExecutive Officer, Director
- Offering amount
- $2.3M
- Amount sold
- $2.3M
- First sale
- Mar 2017
- Incorporated
- Limited Liability Company, Pennsylvania, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Rho Pharmaceuticals raised?
- Rho Pharmaceuticals has disclosed $2.3M raised across 1 round.
- Where is Rho Pharmaceuticals headquartered?
- Rho Pharmaceuticals is headquartered in Glen Mills, US.